| Name | Title | Contact Details |
|---|
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte`s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA`s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense.
Children's Harbor Family Ctr is a Birmingham, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Established over 25 years ago, Medcan is a global leader in assessing clients` overall well-being and inspiring them to live well. We partner with over 1,000 corporate accounts and 40,000 clients to set and achieve health and wellness goals.
Mountain States Health Alliance (MSHA), formed in 1998, is the largest health care system in Northeast Tennessee and Southwest Virginia. Our approximately 9,000 team members, associated physicians and volunteers bring loving care to health care every day in each of our facilities.
Rice Home Medical is a Willmar, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.